Tivic Announces 2024 Annual Meeting of Stockholders
Tivic Announces 2024 Annual Meeting of Stockholders
SAN FRANCISCO – August 2, 2024– Tivic Health Systems, Inc. ("Tivic Health", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the Virtual Annual General Meeting of Shareholders will be held on Friday, August 9, 2024 at 10:00 a.m., Pacific Time. The Company has adopted a virtual format for our Annual Meeting to provide a healthy, consistent, and convenient experience for all stockholders regardless of location.
2024年8月2日,健康技術公司Tivic Health Systems, Inc.(“Tivic Health”,納斯達克:TIVC)宣佈,股東的虛擬年度股東大會將於2024年8月9日星期五上午10:00太平洋時間舉行。公司採用虛擬形式進行年會,爲所有股東提供健康、一致和方便的體驗,無論他們在何處。
WHEN: Friday, August 9, 2024
時間:2024年8月9日星期五
TIME: 10:00 AM Pacific Time
時間:太平洋標準時間上午10:00
WHERE:
地點:
Only stockholders of record at the close of business on June 17, 2024 are entitled to notice of, and to vote at, the Annual Meeting. To attend online and participate in the Annual Meeting, stockholders of record will need to use the control number included on the Notice or proxy card they received in the mail to log into the Annual meeting. Beneficial owners who do not have a control number may gain access to the Annual Meeting by logging into their brokerage firm's website and selecting the stockholder communication mailbox to link through to the Annual Meeting. Instructions should also be provided on the voting instruction card provided by their broker, bank, or other nominee.
截至2024年6月17日營業結束時持有股票的股東有權收到年會通知並參加投票。持股記錄股東需要使用包含在郵件中收到的通知或委託卡上的控制號登錄年度會議。如果沒有控制號碼,有益的所有者可以登錄其券商公司的網站,並選擇股東通訊郵箱以鏈接到年會。他們的經紀人、銀行或其他代表提供的投票指示卡上應該也提供了相關指示。
The company's Proxy Statement and Annual Report on Form 10-K for the year ended December 31, 2023 are both available on the Internet at: .
公司形式的授權聲明和年度報告10-k截至2023年12月31日均可通過互聯網獲得: 。
About Tivic Health
關於Tivic Health
Tivic Health is a commercial health tech company advancing the field of bioelectronic medicine. Tivic Health's technology platforms leverage stimulation of the trigeminal, sympathetic, and vagus nerve structures. Tivic Health's non-invasive and targeted approach to the treatment of inflammatory chronic health conditions gives consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. Tivic Health's first commercial product ClearUP is an FDA approved, award-winning, handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and is available through online retailers and commercial distributors. For more information visit @TivicHealth
Tivic Health是一家商業化健康科技公司,推進生物電醫學領域。 Tivic Health的技術平台利用三叉神經,交感神經和迷走神經結構的刺激。 Tivic Health針對慢性炎症性健康狀況的非侵入式和有針對性的治療方法爲消費者和提供者提供了無需藥物的治療解決方案,具有高安全性、低風險和廣泛應用的特點。 Tivic Health的第一個商業產品ClearUP是一種FDA批准、獲獎的手持生物電氣劍突設備。 ClearUP經過臨床驗證,得到醫生的推薦,可通過在線零售商和商業分銷商獲得。欲了解更多信息,請訪問@TivicHealth
Forward-Looking Statements
前瞻性聲明
This press release may contain "forward-looking statements" that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as "anticipate," "believe," "contemplate," "could," "estimate," "expect," "intend," "seek," "may," "might," "plan," "potential," "predict," "project," "target," "aim," "should," "will" "would," or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Tivic Health Systems, Inc.'s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. Accordingly, you are cautioned not to place undue reliance on such forward-looking statements. For a discussion of risks and uncertainties relevant to the company, and other important factors, see Tivic Health's filings with the SEC, including, its Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 29, 2024, under the heading "Risk Factors"; as well as the company's subsequent filings with the SEC. Forward-looking statements contained in this press release are made as of this date, and Tivic Health Systems, Inc. undertakes no duty to update such information except as required by applicable law.
本新聞稿可能包含“前瞻性聲明”,受到重大風險和不確定性的影響。本新聞稿中除了歷史事實之外的所有陳述都是前瞻性陳述。本新聞稿中包含的前瞻性陳述可以通過使用諸如“預測”、“相信”、“思考”、“可能”、估計”、“期望”、“意圖”、“尋找”、“可能”、“計劃”、“潛在的”、“預測”、“項目”、“目標”、“目的”、“應該”、“將”、“會”等詞語或其他類似的表達式來識別,雖然不是所有的前瞻性陳述都包含這些詞。前瞻性陳述基於Tivic Health Systems, Inc.的當前預期,並且存在難以預測的固有不確定性、風險和假設。此外,某些前瞻性陳述是基於對未來事件的假設,這些假設可能不會被證明準確。由於各種因素的影響,實際結果可能會與任何前瞻性陳述中所包含的結果有所不同。因此,您應謹慎使用這些先前的陳述。有關涉及公司的風險和不確定性以及其他重要因素的討論,請參見Tivic Health向證券交易委員會提交的文件,包括於2024年3月29日提交的截至2023年12月31日結束的年度報告10-k,其中根據“風險因素”的標題;以及公司隨後向證券交易委員會提交的文件。在本新聞稿中包含的前瞻性聲明是截至本日期,Tivic Health Systems, Inc.除根據適用法律規定外,不承擔更新此類信息的義務。
Media Contact:
媒體聯繫人:
Morgan Luke
Morgan Luke
Morgan.Luke@tivichealth.com
Morgan.Luke@tivichealth.com
Investor Contact:
投資者聯繫人:
Hanover International, Inc.
Hanover International, Inc.
ir@tivichealth.com
ir@tivichealth.com